http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112019025325-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_872dd7cd609eb2a937dcfd303d521798 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2818 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2018-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_995850de1f7404b25eff67b099702341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b3bf42b64e14f67a8364eb62182123f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71af797504526b18d8b408c4573cf675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14ef8674acc098ce1eb6a23445b15714 |
| publicationDate | 2020-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-112019025325-A2 |
| titleOfInvention | METHODS FOR TREATING CANCER, FOR MANUFACTURING AN ANTI-ICOS ANTIBODY OR ANTIGEN BINDING PORTION OF THE SAME, FOR MANUFACTURING AN ANTIGEN ANTIBODY OF THE SAME, FOR MANUFACTURING AN ANTIGENO ANTIGENO ANTIGENO ANTIGENE OF THE SAME, ANTI-ICOS ANTIBODY OR ANTIGEN-BINDING FRAGMENT OF THE SAME AND AN ANTI-PD1 ANTIBODY OR ANTIGEN-BINDING FRAGMENT OF THE SAME, ANTI-ICOS ANTIBODY OR ANTI-ANTIGEN BINDING FRAGMENT OF THE SAME AND THE AGE OF OR ANTIGEN BINDING FRAGMENT OF THE SAME, USE OF AN ANTI-ICOS ANTIBODY OR ANTIGEN BINDING PORTION OF THE SAME AND ANTI-PD1 ANTIBODY OR ANTIGEN BINDING PORTION, POLYNUCLEOTIDE, VECTOR, AND, CÉPÉ |
| abstract | the present invention provides methods for treating cancer in a patient in need thereof, the method comprising administering to the patient an effective amount of an agent targeting the human ico and an effective amount of an agent targeting the human pd 1 or human pd-11 sequentially . the present invention also provides an anti-single antibody or antigen binding fragment thereof and an anti-pd1 antibody or antigen binding fragment thereof for sequential use in the treatment of cancer in a human in need thereof. the present invention provides an anti-single antibody or antigen binding fragment thereof and an anti-pd-11 antibody or antigen binding fragment thereof for sequential use in the treatment of cancer in a human in need thereof. |
| priorityDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 523.